Overview

A Study of the Efficacy and Safety of Long-acting Injectable Risperidone and Risperidone Tablets in Patients With Schizophrenia

Status:
Completed

Trial end date:
2006-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the effectiveness and safety of risperidone, formulated as a long-acting injectable drug, compared with risperidone tablets in the treatment of patients with schizophrenia.

Phase:

Phase 3

Details

Lead Sponsor:

Janssen Pharmaceutical K.K.

Treatments:

Risperidone